Aradigm Corporation (OTC BB: ARDM)

Aradigm Corporation (OTC BB: ARDM), an emerging specialty pharmaceutical company, is committed to developing and commercializing a portfolio of drugs designed to treat severe respiratory diseases. With its clinical expertise, targeted development efforts, and strength of a well accomplished leadership team, the company is poised to capitalize on niche opportunities for new and improved products used in the treatment of severe respiratory disease. For further information, visit the Company’s web site at www.aradigm.com.